NCT00093457 2023-08-04
Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer
Canadian Cancer Trials Group
Phase 2 Completed
Clinical Trials
6 trialsNCT00064350 2023-06-29
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01804374 2015-06-17
SERIO
Italian Sarcoma Group
Phase 2 Completed
NCT01158287 2014-12-31
Sorafenib. ICORG 06-41, V4
Cancer Trials Ireland
Phase 2 Completed
NCT01736878 2013-05-17
SUMMIT
Eanm Research Ltd
Phase 2 Withdrawn
NCT00889057 2013-03-28
Sorafenib in Relapsed High Grade Osteosarcoma
Italian Sarcoma Group
Phase 2 Completed